Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-7.68 Insider Own15.79% Shs Outstand2.90M Perf Week17.78%
Market Cap1.48M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.45M Perf Month-2.86%
Income-9.74M PEG- EPS next Q- Inst Own14.76% Short Float0.80% Perf Quarter-36.27%
Sales0.00M P/S- EPS this Y- Inst Trans-67.38% Short Ratio0.07 Perf Half Y-83.06%
Book/sh1.25 P/B0.41 EPS next Y- ROA-122.06% Short Interest0.02M Perf Year-88.41%
Cash/sh0.92 P/C0.56 EPS next 5Y- ROE-155.50% 52W Range0.39 - 13.98 Perf YTD-58.20%
Dividend Est.- P/FCF- EPS past 5Y-62.82% ROI-274.49% 52W High-96.35% Beta1.05
Dividend TTM- Quick Ratio2.26 Sales past 5Y-25.00% Gross Margin-140.38% 52W Low30.77% ATR (14)0.08
Dividend Ex-Date- Current Ratio2.26 EPS Y/Y TTM20.96% Oper. Margin0.00% RSI (14)48.74 Volatility13.13% 16.32%
Employees10 Debt/Eq0.10 Sales Y/Y TTM-100.00% Profit Margin- Recom3.00 Target Price32.00
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q60.41% Payout- Rel Volume7.21 Prev Close0.46
Sales Surprise- EPS Surprise-155.21% Sales Q/Q- Earnings- Avg Volume265.12K Price0.51
SMA20-1.51% SMA50-7.52% SMA200-74.72% Trades Volume1,911,727 Change11.62%
Mar-28-24 11:53PM
Jan-02-24 05:58PM
Dec-28-23 08:00AM
Dec-27-23 09:00AM
Nov-09-23 04:05PM
07:59AM Loading…
Aug-28-23 07:59AM
Aug-25-23 08:00AM
Aug-16-23 07:00AM
Aug-10-23 04:05PM
Jul-24-23 08:30AM
Jul-21-23 07:00AM
May-31-23 06:36AM
May-19-23 07:00AM
May-10-23 07:30AM
Mar-20-23 04:15PM
08:00AM Loading…
Feb-16-23 08:00AM
Nov-13-22 08:01AM
Nov-09-22 08:00AM
Aug-30-22 04:05PM
Aug-24-22 06:09AM
Aug-16-22 07:30AM
Jul-27-22 07:30AM
Jul-26-22 04:30PM
Jul-06-22 07:30AM
Jun-09-22 07:30AM
May-05-22 11:21AM
Apr-20-22 04:10PM
Mar-28-22 07:00AM
Mar-24-22 07:00AM
Mar-17-22 06:53AM
07:00AM Loading…
Mar-10-22 07:00AM
Jan-31-22 07:00AM
Jan-13-22 11:29AM
Jan-11-22 04:19PM
Jan-05-22 08:15AM
Dec-16-21 09:11AM
Dec-07-21 07:25AM
Nov-10-21 08:15AM
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dey IndranilPresident and CEODec 13 '23Buy3.275001,63528,526Dec 14 04:16 PM
Dey SvetlanaDirectorDec 13 '23Buy3.075001,5351,500Dec 14 04:17 PM